Now live: Pro — the full 13F research suite for serious investorsSee pricing →
ABG Innovation Capital Partners III GP Ltd

Q1 2025 · 13F-HR

ABG Innovation Capital Partners III GP Ltdholdings as filed

Filed 2025-05-15 · accession 0000950123-25-005580

$800,161
Reported value
3
Positions
2025-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
14843C105CSTLCASTLE BIOSCIENCES INC$735,67591.9%36,747CommonSOLE
00032Q104WHWKWHITEHAWK THERAPEUTICS INC$47,4655.93%26,666CommonSOLE
87166L209SYBXSYNLOGIC INC$17,0212.13%13,727CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.